MedTech News
.................... by Andrew Celentano
Brain–computer interface detects hidden awareness in unresponsive patients
A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has been demonstrated by researchers at the University of Bath in the U.K.
A blood protein can flag dementia risk decades before symptoms appear
A recent study found that a blood protein called GDF15, which is released when cells are under stress, could serve as one of the earliest warning signs of dementia.
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the “Company”), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Saluda’s CAP24 paddle lead, allowing it to be marketed and sold in the U.S.
Rare Powassan Virus Can Lead to Serious Brain or Spinal Cord Inflammation, and Cases are Rising in the U.S.
Powassan virus spreads through infected ticks, raising concern in Maine and Rhode Island, and symptoms can make the infection dangerous.
Moving Toward Better Tests and Treatments for Lyme Disease
New study finds biomarkers that may someday help clinicians better detect—and possibly cure—early and persistent Borrelia burgdorferi infections
Blood test spots hidden pancreatic cancer after treatment
Sensitive test looking for key genetic mutation detects high-risk patients missed by standard testing
Aurenar gets FDA breakthrough nod for noninvasive neuromod tech
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation system.
Novocure earns CE mark for Optune Pax pancreatic cancer treatment device
Novocure (Nasdaq:NVCR) announced today that its Optune Pax device for treating pancreatic cancer received CE mark approval.